Latest mRNA Vaccine for RSV Wins Expedited Review

Past attempts to develop it have ended in tragedy, with two babies dying despite appearing to tolerate it at first.

STORY AT-A-GLANCE

• Moderna just moved one step closer to bringing mRNA-1345, an RSV shot, to market

• The U.S. Food and Drug Administration granted the experimental shot fast-track designation in August 2021

• Now, Moderna’s mRNA RSV shot has been given Breakthrough Therapy Designation, which allows for faster development and an expedited review period

• RSV is us…